Name | Aceglutamide |
Synonyms | AC-GLN-OH Ac-Gln-OH Aceglutamide Acetylglutamide N-ACETYL GLUTAMINE ACETYL-L-GLUTAMINE N-Acetyl-L-glutamine L-GLUTAMINE, N-ACETYL- ACETYL-L-GLUTAMINE, N- L-GLUTAMINE, N2-ACETYL- ALPHA-N-ACETYL-L-GLUTAMINE L-2-ACETAMIDOGLUTARAMIC ACID |
CAS | 35305-74-9 |
EINECS | 219-647-7 |
InChI | InChI=1/C7H12N2O4/c1-4(10)9-5(7(12)13)2-3-6(8)11/h5H,2-3H2,1H3,(H2,8,11)(H,9,10)(H,12,13)/t5-/m0/s1 |
Molecular Formula | C7H12N2O4 |
Molar Mass | 188.18 |
Density | 1.290±0.06 g/cm3(Predicted) |
Melting Point | 206-208°C |
Boling Point | 430.5±40.0 °C(Predicted) |
Specific Rotation(α) | -12.4 º (c=2.5% in H2O) |
Solubility | DMSO (Slightly, Heated, Sonicated), Water (Sparingly, Heated, Sonicated) |
Appearance | Solid |
Color | White to Off-White |
pKa | 2.19±0.10(Predicted) |
Storage Condition | Sealed in dry,Room Temperature |
MDL | MFCD00038159 |
Physical and Chemical Properties | White crystalline substance; Odorless, tasteless; Soluble in water, ethanol and ethyl acetate; mp 197 ℃. |
Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. |
WGK Germany | 3 |
Reference Show more | 1. Fang Yuchen, Wan Hai Tong, Yu Li, etc. Pharmacokinetics of Safflower Extract and Aceglutamide Injection active ingredient in cerebral ischemia model rats [J]. Chinese Journal of Traditional Chinese Medicine, 2018, 043(009):1940-1945. 2. Xu, Shouchao, et al. "A Study on Acetylglutamine Pharmaceutics in Rat Blood and Brain Based on Liquid Chromatography-Tandem Mass spectroscopy and Microdialysis Technique." Frontiers in Pharmacology 11 (2020): 508. 3. [IF=6.057] Mengnan Jiang et al."Rapid electrochemical detection of domoic acid based on polydopamine/reduced graphene oxide coupled with in-situ imprinted polyacrylamide."Talanta. 2022 Jan;236:122885 |
This product is N2-acetyl glutamine. The content of C7H12N204 shall not be less than 98.0% calculated as dried product.
The melting point of this product (General 0612) is 194~198°C.
take this product, precision weighing, adding water to dissolve and quantitatively dilute the solution containing 20mg per lml, according to the law (General 0621), the specific rotation is -11. 5 ° to 13 °. 5 degrees.
take 0.50g of this product, add water 20ml to dissolve, according to UV-visible spectrophotometry (General rule 0401), measure the transmittance at 430nm wavelength, not less than 95.0%.
take 0.40g of this product and check it according to law (General rule 0801). Compared with the control solution made of 8.0ml of standard sodium chloride solution, it should not be more concentrated (0.02%).
take this product 1.25g, inspection according to law (General 0803), should meet the requirements (0.0004%).
take this product, add mobile phase to dissolve and dilute to make a solution containing about 1 mg per 1ml as a test solution; Take 1ml for precision measurement and put it in a 100ml measuring flask, dilute to the scale with the mobile phase, shake, and serve as a control solution. According to the chromatographic conditions under the content determination item, 20 u1 of the test solution and the control solution are respectively injected into the liquid chromatograph, and the chromatogram is recorded to 3 times of the retention time of the main component peak. If there are impurity peaks in the chromatogram of the test solution, the area of a single impurity peak shall not be greater than the area of the main peak of the control solution (1.0% ) , the sum of each impurity peak area shall not be greater than 2 times (2.0%) of the main peak area of the control solution.
take this product, in 105C dry to constant weight, weight loss should not exceed 1.0% (General rule 0831).
not more than 0.1% (General rule 0841).
take this product l. Add 23ml of water, heat it to dissolve if necessary, cool it, add 2ml of acetate buffer (pH3.5) and an appropriate amount of water to 25ml, and check it according to law (General rule 0821, Law 1), heavy metals should not be more than 10 parts per million.
measured by high performance liquid chromatography (General 0512).
psychostimulants.
light shielding, sealed storage.
This product is a sterile aqueous solution of aceglutamide. Aceglutamide-containing (C7H12N204) shall be between 90.0% and 110.0% of the labeled amount.
The pH value should be 4.5 to 7. 0 (General 0631).
an appropriate amount of the product is taken and diluted with the mobile phase to prepare a solution containing about 1 ml of acetyl glutamine in lm g as a test solution; The determination is carried out according to the method under the item of acetyl glutamine. If there are impurity peaks in the chromatogram of the test solution, the area of a single impurity peak shall not be more than 2 times (2.0%) the area of the main peak of the control solution, the sum of each impurity peak area shall not be greater than 3 times (3.0%) of the main peak area of the control solution.
take this product, check according to law (General 1143), the amount of endotoxin per 1 mg aceglutamide should be less than 0.25EU.
This product is treated by membrane filtration method, washed with 0.1% sterile peptone aqueous solution (not less than 1101 per membrane), with Staphylococcus aureus as the positive control bacteria, and checked according to law (general rule), the requirements shall be met. Others should comply with the relevant provisions under injections (General rule 0102).
precise amount of this product is appropriate, diluted with mobile phase to prepare a solution containing about 0.1 mg of aceglutamide per 1 ml, and determined according to the method under the content determination of aceglutamide.
Same as aceglutamide.
(l )2ml:0.lg (2 )5ml:0.25g (3 )5ml:0. 3g (4)5ml : 0.6g (5) 10ml:0.5g (6)20ml : 0.6g
light shielding, sealed storage.
use | used for biochemical research, medically used as a brain function improvement drug, used for liver coma, brain trauma, brain tumor, paralysis, mental retardation, memory disorders and other diseases. |
production method | using L-glutamine and acetic anhydride as raw materials, the product is refined through acylation reaction. |